STOCK TITAN
  1. Home
  2. News
  3. OFIX

Orthofix Medical Inc. - OFIX STOCK NEWS

Welcome to our dedicated page for Orthofix Medical news (Ticker: OFIX), a resource for investors and traders seeking the latest updates and insights on Orthofix Medical stock.

Orthofix Medical Inc. (NASDAQ: OFIX) is a leading medical device company providing orthopedic and spine solutions to healthcare providers worldwide. Founded in 1980 by orthopedic researcher Giovanni De Bastiani in Verona, Italy, the company has expanded to over 900 employees and operates in the U.S., Italy, Germany, France, the UK, Brazil, Australia, and Puerto Rico. Orthofix's products serve patients in more than 70 countries, focusing on enhancing patient quality of life through innovative medical solutions.

The company is structured into four strategic business units:

  • BioStim: Offering bone growth stimulators using pulsed electromagnetic field technology.
  • Biologics: Providing regenerative tissue products and biological solutions for bone and soft tissue repair.
  • Extremity Fixation: Specializing in devices for fracture repair, deformity correction, and bone reconstruction.
  • Spine Fixation: Delivering comprehensive solutions for spinal implants and bone healing therapies.

Orthofix is committed to clinical research and innovation, continuously introducing new products to meet the evolving needs of the medical community. The company maintains strong partnerships with esteemed institutions like the Texas Scottish Rite Hospital for Children and the Musculoskeletal Transplant Foundation, reflecting its dedication to advancing orthopedic and spine care.

The majority of Orthofix's sales come from its global spine segment, primarily in the United States. The company's products are distributed through sales representatives, distributors, and subsidiaries across North America, Europe, and other international markets. Orthofix's solutions cater to hospitals, physicians, healthcare providers, and patients, aiming to improve treatment outcomes and patient well-being.

Latest News: Stay updated with the latest developments, product launches, and financial reports from Orthofix Medical Inc. to keep track of the company's performance and strategic initiatives.

News

Orthofix Names Andres Cedron as New Chief Legal Officer

Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) appoints Andres Cedron as Chief Legal Officer, bringing extensive experience from Stryker Cedron's background in corporate governance, SEC compliance, and mergers and acquisitions positions him well to drive Orthofix's profitability and growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
News

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) announced the appointment of Lucas Vitale as Chief People and Business Operations Officer. Vitale brings extensive experience in spine and orthopedics, having served in key roles at companies like NuVasive, Inc. His role will focus on integration and business transformation strategies to support future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
none
-
News

Orthofix Reports Fourth Quarter and Full Year 2023 Results

Rhea-AI Summary
Orthofix Medical Inc. (OFIX) reported strong financial results for Q4 2023 with net sales of $200.4 million, a 64% increase on a reported basis. The company achieved 15% growth in Bone Growth Therapies sales, marking four consecutive quarters of double-digit growth. Despite a net loss of $22 million, the Non-GAAP Adjusted EBITDA was $20 million, representing 96% growth over the previous year. Full-year net sales reached $746.6 million, a 62% increase, with Non-GAAP adjusted EBITDA of $46.3 million, a 69% growth over the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.69%
Tags
earnings
News

Orthofix Announces New President for Bone Growth Therapies Business

Rhea-AI Summary
Orthofix Medical Inc. appoints Jason Shallenberger as President of Bone Growth Therapies and realigns its Spine business unit. Shallenberger, a seasoned sales leader, has a successful track record of driving double-digit growth. The move aims to enhance the company's focus on Biologics and Enabling Technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
News

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

Rhea-AI Summary
Orthofix Medical Inc. (OFIX) will report its Q4 and full year 2023 financial results on March 5, 2024. A conference call and webcast will follow to discuss the outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
earnings
-
News

Orthofix Announces Commercial Partnership with MRIguidance

Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) has announced an agreement with MRIguidance to distribute its BoneMRI™ imaging software in the U.S. The company completed the world's first eight cases using BoneMRI software with 7D's FLASH™ Navigation System, providing completely radiation-free preoperative imaging and spinal navigation. The 7D FLASH Navigation System uses visible light to create a three-dimensional image for surgical navigation, enabling faster and more efficient spinal procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
partnership
News

Julie Andrews Begins as New Chief Financial Officer at Orthofix

Rhea-AI Summary
Orthofix Medical Inc. (OFIX) announced the appointment of Julie Andrews as the new Chief Financial Officer. Ms. Andrews brings over 25 years of leadership experience in the medical device sector, previously serving as CFO for Smart Wires Technology and Senior Vice President, Global Finance for Wright Medical Group. Orthofix CEO, Massimo Calafiore, expressed confidence in Ms. Andrews' ability to drive sustainable shareholder value. Ms. Andrews also expressed her excitement to join Orthofix and work towards improving the company's performance and accelerating its business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
News

Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results

Rhea-AI Summary
Orthofix Medical Inc. (OFIX) reports a 64% increase in net sales to $200.3 million for Q4 2023, with Bone Growth Therapies growing 15% and U.S. Spinal Implants, Biologics, and Enabling Technologies growing 4%. Full-year net sales for 2023 were $746.5 million, a 62% increase over 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.78%
Tags
none
-
News

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ: OFIX) announced the appointment of Massimo Calafiore as President and CEO, effective immediately, and Julie Andrews as Chief Financial Officer, effective January 15, 2024. Calafiore brings extensive experience, and Andrews has a strong financial background. Catherine Burzik, Chair of the Board, expressed confidence in the new executives' vision and leadership. Calafiore stated his commitment to the company's mission and welcomed Andrews to the team.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
management
News

Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis

Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) announced new data from a study on Pulsed Electromagnetic Field (PEMF) stimulation as a therapy for spinal fusion procedures. The study showed a high rate of successful fusion and significant improvements in pain, function, and quality of life for patients at risk for pseudarthrosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
none

FAQ

What is the current stock price of Orthofix Medical (OFIX)?

The current stock price of Orthofix Medical (OFIX) is $18.91 as of November 22, 2024.

What is the market cap of Orthofix Medical (OFIX)?

The market cap of Orthofix Medical (OFIX) is approximately 712.3M.

What does Orthofix Medical Inc. specialize in?

Orthofix Medical Inc. specializes in orthopedic and spine solutions, offering a range of products for bone growth, fracture repair, and spinal treatments.

Where is Orthofix Medical Inc. headquartered?

Orthofix Medical Inc. is headquartered in the United States with additional locations in Italy, Germany, France, the UK, Brazil, Australia, and Puerto Rico.

What are the main business units of Orthofix?

The main business units are BioStim, Biologics, Extremity Fixation, and Spine Fixation.

How does Orthofix distribute its products?

Orthofix distributes its products through sales representatives, distributors, and subsidiaries across North America, Europe, and other international markets.

What partnerships does Orthofix have?

Orthofix has partnerships with organizations such as the Texas Scottish Rite Hospital for Children and the Musculoskeletal Transplant Foundation.

In how many countries are Orthofix products available?

Orthofix products are available in more than 70 countries around the world.

What segment generates the majority of Orthofix's sales?

The majority of Orthofix's sales come from the global spine segment, particularly in the United States.

What are some key products offered by Orthofix?

Key products include bone growth stimulators, spinal implants, regenerative tissue products, and devices for fracture repair and deformity correction.

How many employees does Orthofix have?

Orthofix has over 900 employees.

When was Orthofix Medical Inc. founded?

Orthofix Medical Inc. was founded in 1980 in Verona, Italy.

Stock OFIX logo
Orthofix Medical Inc.

Nasdaq:OFIX

OFIX Rankings

#2829 Ranked by Market Cap
N/A Ranked by Dividends

OFIX Stock Data

712.31M
36.31M
4.99%
92.32%
6.57%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
LEWISVILLE